Erasmus Medical Center Dept of Internal Medicine Rotterdam
Netherlands
Presentation(s) of this author
Wed, March 26th, 2014, 14:30 - 14:40
Blocking follicular T-helper cell driven B-cell stimulation by the IL-21-receptor antagonist is a novel therapeutic option in kidney-transplant patients